Will Kala Pharmaceuticals (KALA) Report Negative Q4 Earnings? What You Should KnowZacks Investment Research • 02/17/22
Kala Pharmaceuticals (KALA) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 11/15/21
Kala Pharmaceuticals' (KALA) CEO Mark Iwicki on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/15/21
Kala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/15/21
Kala Pharmaceuticals Acquires Combangio, Expanding its Pipeline with a Clinical-Stage Novel Biologic for the Treatment of Persistent Corneal Epithelial Defect (PCED) and other Rare Ocular Surface DiseasesGlobeNewsWire • 11/15/21
Kala Pharmaceuticals to Participate in Upcoming Investor Conferences in November 2021GlobeNewsWire • 11/11/21
Kala Pharmaceuticals to Report Third Quarter 2021 Financial Results and Host Conference CallGlobeNewsWire • 11/08/21
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September 2021GlobeNewsWire • 09/07/21
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/05/21
Kala Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/05/21
Earnings Preview: Kala Pharmaceuticals (KALA) Q2 Earnings Expected to DeclineZacks Investment Research • 07/29/21
Kala Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference CallGlobeNewsWire • 07/29/21
Kala Pharmaceuticals to Present at Jefferies 2021 Virtual Healthcare ConferenceBusiness Wire • 05/27/21
Kala Pharmaceuticals to Present at BofA Securities 2021 Healthcare ConferenceBusiness Wire • 05/06/21
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/05/21